| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |